1. Home
  2. TNYA vs HLP Comparison

TNYA vs HLP Comparison

Compare TNYA & HLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.41

Market Cap

153.2M

Sector

Health Care

ML Signal

HOLD

Logo Hongli Group Inc.

HLP

Hongli Group Inc.

SELL

Current Price

$3.13

Market Cap

165.2M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
TNYA
HLP
Founded
2016
2021
Country
United States
China
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
153.2M
165.2M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
TNYA
HLP
Price
$0.41
$3.13
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
★ $3.20
N/A
AVG Volume (30 Days)
★ 3.7M
102.6K
Earning Date
11-09-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 54.96
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$51.63
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$0.34
52 Week High
$2.02
$3.00

Technical Indicators

Market Signals
Indicator
TNYA
HLP
Relative Strength Index (RSI) 26.96 87.09
Support Level N/A $0.85
Resistance Level $0.81 N/A
Average True Range (ATR) 0.04 0.19
MACD -0.01 0.03
Stochastic Oscillator 23.26 95.55

Price Performance

Historical Comparison
TNYA
HLP

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

About HLP Hongli Group Inc.

Hongli Group Inc is an offshore holding company. Through its subsidiaries, it is engaged in the cold-rolled steel profile manufacturing in China. Its main business operation focuses on the design, production, deep processing, and sales of custom-made profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation industries. The group operates in a single segment, which manufactures and sells agricultural machinery cab assemblies, construction machinery cab assemblies, excavator cab assemblies, and special-shaped steel pipes. It generates the majority of its reveneue from PRC.

Share on Social Networks: